# Xavier Mariette

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xavier-mariette/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,131 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 111 |
| i10-index | 445 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5051196993 |
| ORCID iD | https://orcid.org/0000-0002-4244-5417 |
| Works | 1,026 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [Genetics of rheumatoid arthritis contributes to biology and drug discovery](https://scholariq.org/papers/genetics-of-rheumatoid-arthritis-contributes-to-biology-and-drug-discovery/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Immune-related adverse events of checkpoint inhibitors](https://scholariq.org/papers/immune-related-adverse-events-of-checkpoint-inhibitors/)
- [Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia](https://scholariq.org/papers/effect-of-tocilizumab-vs-usual-care-in-adults-hospitalized-with-covid-19-and/)
- [Treat-to-target in systemic lupus erythematosus: recommendations from an international task force](https://scholariq.org/papers/treat-to-target-in-systemic-lupus-erythematosus-recommendations-from-an/)
- [Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study](https://scholariq.org/papers/lack-of-placental-transfer-of-certolizumab-pegol-during-pregnancy-results-from/)
- [A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)](https://scholariq.org/papers/a-framework-for-remission-in-sle-consensus-findings-from-a-large-international/)
- [Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial](https://scholariq.org/papers/effect-of-anakinra-versus-usual-care-in-adults-in-hospital-with-covid-19-and/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Salivary Gland Disorders and Functions](https://scholariq.org/topics/salivary-gland-disorders-and-functions/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.